Defining the burden of antibiotic resistance and LRTI
| Antibiotic use in Europe (community vs. hospital)
Herman Goossens (Antwerp, Belgium) | | | | | |  | | | | |
|
| Antibiotic resistance in Europe
Hajo Grundmann (Bilthoven, Netherlands) | | | | | | | | | | |
|
| Healthcare burden of LRTI in Europe in primary care: patient morbidity and mortality
Kerry Hood (Cardiff, UK) | | | | | | | | | | |
|
| Healthcare burden of hospitalised patients with LRTI in Europe: patient morbidity and mortality (Hospital care)
John Macfarlane (Nottingham, UK) | | | | | | | | | | |
|
| News from GRACE: Diagnosis and management of LRTI in Europe: attitudes of doctors and patients
Kerry Hood (Cardiff, UK) | | | | | | | | | | |
|
| News from GRACE: Ongoing studies on aetiology, diagnosis and treatment of LRTI
Paul Little (Southampton, UK) | | | | | | | | | | |
|
| Healthcare burden of LRTI in Europe, socioeconomic considerations
Jo Coast (Birmingham, UK) | | | | | | | | | | |
|
| Role and impact of pneumococcal polysaccharide vaccine on respiratory tract infection
Ake Ortqvist (Stockholm, Sweden) | | | | | | | | | | |
|
| Predicting the impact of paediatric pneumococcal conjugate vaccine on antibiotic resistance and non-vaccine recipients in Europe
Javier Diez Domingo (Valencia, Spain) | | | | | | | | | | |
|
| Seasonal influenza - modelling the impact and defining opportunities for its minimisation
Jonathan Van-Tam (London, UK) | | | | | | | | | | |
|
